{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/polycystic-ovary-syndrome/background-information/causes/","result":{"pageContext":{"chapter":{"id":"86ec422e-1b3a-5c12-b4df-64886e831aea","slug":"causes","fullItemName":"Causes","depth":2,"htmlHeader":"<!-- begin field 7368fdb2-9a69-4c0c-8402-24a856853033 --><h2>What causes it?</h2><!-- end field 7368fdb2-9a69-4c0c-8402-24a856853033 -->","summary":"","htmlStringContent":"<!-- begin item 04e2faf6-384e-4390-a08f-96d029f00085 --><!-- begin field 9ae8807d-a827-469e-85d4-400b87777e3c --><ul><li><strong>The cause of polycystic ovary syndrome (PCOS) is unknown. </strong>It is likely to be multifactorial, with both genetic and environmental factors playing a part [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycystic-ovary-syndrome/references/\">Conway, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/polycystic-ovary-syndrome/references/\">Witchel, 2015</a>]. </li><li><strong>Insulin resistance</strong> <strong>and consequent compensatory hyperinsulinaemia are key factors in the pathogenesis of PCOS in many, but not all, women. </strong>Effects of hyperinsulinaemia include:<ul><li>Reduced production of sex hormone-binding globulin (SHBG) in the liver — as testosterone is bound to SHBG, more testosterone is available in the blood in the biologically active unbound form, even though the total testosterone level may be normal or only modestly elevated [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycystic-ovary-syndrome/references/\">Hopkinson et al, 1998</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/polycystic-ovary-syndrome/references/\">Ehrmann, 2005</a>].</li><li>Increased androgen production (via several mechanisms) — an excessive increase in androgen production stops follicular development and therefore causes anovulation (failure of the ovaries to produce eggs) and menstrual disturbance [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycystic-ovary-syndrome/references/\">Ehrmann, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/polycystic-ovary-syndrome/references/\">Costello et al, 2007</a>].</li><li>Insulin resistance can also lead to weight gain, which can make PCOS symptoms worse. Excess body fat causes the body to produce even more insulin.</li></ul></li><li><strong>Hormonal imbalance is common in women with PCOS.</strong><ul><li>Serum luteinizing hormone (LH) levels are elevated in approximately 40% of women with PCOS due to increased production from the anterior pituitary (increased amplitude and frequency of LH pulses) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycystic-ovary-syndrome/references/\">Balen et al, 1995</a>].</li><li>The theca cells of the ovary produce excess androgens due to hyperinsulinaemia or increased serum levels of LH.<ul><li>When the concentration of LH increases relative to that of follicle-stimulating hormone, the ovaries preferentially synthesize androgens from androgen precursors rather than oestrogens [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycystic-ovary-syndrome/references/\">Ehrmann, 2005</a>].</li><li>The theca cells in women with PCOS seem to be more efficient at converting androgen precursors to testosterone than normal theca cells [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycystic-ovary-syndrome/references/\">Ehrmann, 2005</a>].</li></ul></li><li>Women with PCOS may have increased serum oestrogen levels.<ul><li>Follicular development is arrested at some stage short of full maturation of an ovulatory follicle. Therefore, although there is no ovulation, oestrogen production continues and there is no oestrogen deficiency. However, as a result of continued exposure to oestrogen unopposed by progestogen, the endometrium may become hyperplastic [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycystic-ovary-syndrome/references/\">Baird, 1997</a>]. In addition, testosterone is converted to oestrogen in peripheral fat [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycystic-ovary-syndrome/references/\">Balen et al, 2005</a>].</li></ul></li></ul></li><li><strong>PCOS appears to have a genetic link in some cases, as it sometimes runs in families.</strong> However, specific genes associated with the condition have not yet been identified [<a class=\"bibliography-reference internal-reference\" href=\"/topics/polycystic-ovary-syndrome/references/\">Rosenfield, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/polycystic-ovary-syndrome/references/\">Ding, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/polycystic-ovary-syndrome/references/\">BMJ, 2018</a>].</li></ul><!-- end field 9ae8807d-a827-469e-85d4-400b87777e3c --><!-- end item 04e2faf6-384e-4390-a08f-96d029f00085 -->","topic":{"id":"daaf23b6-59bf-5fa9-96d9-6d98f028d2bd","topicId":"90f70ae3-1caf-4e74-8397-cf2655cfb10c","topicName":"Polycystic ovary syndrome","slug":"polycystic-ovary-syndrome","lastRevised":"Last revised in September 2018","chapters":[{"id":"6f41b5a4-2e7e-5469-91c8-15331570cb8c","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"5ad66803-f217-58c6-ad92-d9db6491cb26","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"132cf0f7-983a-59b8-aa99-10f350089b7c","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"d45a2f22-c9b6-5ee0-afb6-8ae3d0397d9f","slug":"changes","fullItemName":"Changes"},{"id":"e3852569-27c3-5e63-ab2f-2b92dcfe5262","slug":"update","fullItemName":"Update"}]},{"id":"f1fe2489-77fe-5403-977f-d3603e5bae1e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"048d9ada-61af-59a9-971e-42aed733010a","slug":"goals","fullItemName":"Goals"},{"id":"845cd360-b1c4-50ee-a60f-5ec2ce05b2b8","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6bed55f9-2ee7-578e-8770-b9a5e2053955","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"0afb7a34-d84c-5ad9-bcc3-0dc5345cd2b8","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f7587b9f-e03a-5ba0-b6c5-173412097eb9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b7749edb-c354-5cb9-adc7-04cbe456d37d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"390c9f6a-9392-5672-8a5d-2945f5be467d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"5ae79977-6f68-54e7-bae5-d3a83aa4bad7","slug":"definition","fullItemName":"Definition"},{"id":"86ec422e-1b3a-5c12-b4df-64886e831aea","slug":"causes","fullItemName":"Causes"},{"id":"87943c47-132e-5d7b-bba7-9f5fd8d2fdd8","slug":"prevalence","fullItemName":"Prevalence"},{"id":"fd9eddac-eb60-523a-9a51-e94719b6fef4","slug":"complications","fullItemName":"Complications"},{"id":"104e8e2a-4d4d-5fc6-b68f-5337dd3ccc87","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"26e7fb06-0e4c-5c05-aea8-632061b95e52","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6f9e9e17-1a64-5142-813c-89d3dc869c6d","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"483e27e7-00c5-5c3a-b61b-d00edbcafdd7","slug":"investigations","fullItemName":"Investigations"},{"id":"6a10f0bc-d2b9-504d-beb4-a033a4cfb16b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"82ce27d1-1cdc-5a75-8d26-8bbb3d8d62d7","fullItemName":"Management","slug":"management","subChapters":[{"id":"5c7d454c-e837-5db4-96b6-d7259cedcbb1","slug":"management-adults","fullItemName":"Scenario: Management - adults"},{"id":"762c879d-8353-5b98-98e3-cd5e9dd9238e","slug":"management-adolescents","fullItemName":"Scenario: Management - adolescents"}]},{"id":"980e12cc-a3a7-5006-9004-9a3817403978","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"8c324c3d-d93a-5a1b-9a8f-070221373b1a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0096e783-16f8-5f5a-9660-d3685b777a10","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"af33ae46-9b14-5c06-98b3-689fc80c683f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"61bd6f68-6b5a-5980-aec9-07bcbf6dc232","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3d02f180-e5e5-5a10-a991-a415041c663f","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"17c9b913-2bf1-5468-a926-0f8643a69cc1","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"696b4fff-16f7-5d8a-a5d1-da81a7a53ffc","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"390c9f6a-9392-5672-8a5d-2945f5be467d","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}